Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study
Oncology and Therapy · 2026-06 · 14 (2) · 721-734
DOI: 10.1007/s40487-026-00437-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology and Therapy, online erschienen am 03.05.2026. Verfasst von Benoît Godbert und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hôpital Robert Schuman, Uneos, Metz, France. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bristol-Myers Squibb.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hôpital Robert Schuman, Uneos, Metz, France.
- Institut Curie, 26 rue d'Ulm, 75248, Paris Cedex 05, France.
- Bristol Myers Squibb, Rueil-Malmaison, France.
- Leon Berard Center, Lyon, France.
- Bristol Myers Squibb, Uxbridge, UK.
- Service de Pneumologie, CHU Pontchaillou, Rennes, France.
Förderung
- Bristol-Myers Squibb
Zitieren
APA
Godbert, B., Gobbini, E., Khalife, Y., Decroisette, C., Brellier, F., Lena, H., Fleuriet, A., Zysman, M., Egenod, T., & Girard, N. (2026). Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study. Oncology and Therapy, 14(2), 721-734. https://doi.org/10.1007/s40487-026-00437-8
Vancouver
Godbert B, Gobbini E, Khalife Y, Decroisette C, Brellier F, Lena H, et al. Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study. Oncology and Therapy. 2026;14(2):721-734. doi:10.1007/s40487-026-00437-8
BibTeX
@article{Godbert2026,
author = {Godbert, Benoît and Gobbini, Elisa and Khalife, Yaacoub and Decroisette, Chantal and Brellier, Florence and Lena, Hervé and Fleuriet, Anne and Zysman, Maeva and Egenod, Thomas and Girard, Nicolas},
title = {Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study},
journal = {Oncology and Therapy},
year = {2026},
volume = {14},
number = {2},
pages = {721--734},
doi = {10.1007/s40487-026-00437-8}
}
EUVIMED